Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Tuberculosis

  Free Subscription


01.01.2020

2 Am J Respir Crit Care Med
4 Antimicrob Agents Chemother
1 BMJ
3 Clin Infect Dis
3 Emerg Infect Dis
1 Eur J Clin Microbiol Infect Dis
3 Eur Respir J
1 Infect Immun
11 Int J Tuberc Lung Dis
1 J Bacteriol
2 J Immunol
1 Lancet
4 Lancet Infect Dis
14 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. YOON C, Semitala FC, Cattamanchi A
    Reply to Parker: Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities.
    Am J Respir Crit Care Med. 2019;199:665.
    PubMed     Text format    

  2. PARKER RA
    Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities.
    Am J Respir Crit Care Med. 2019;199:664.
    PubMed     Text format    


    Antimicrob Agents Chemother

  3. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
    PubMed     Text format     Abstract available

  4. KWARA A, Yang H, Antwi S, Enimil A, et al
    Effect of rifampin/isoniazid-containing antituberculosis therapy on efavirenz pharmacokinetics in HIV-infected children aged 3 to 14 years old.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01657.
    PubMed     Text format     Abstract available

  5. ABDELWAHAB MT, Leisegang R, Dooley KE, Mathad JS, et al
    Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in South African Pregnant Women with Tuberculosis and HIV.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01978.
    PubMed     Text format     Abstract available

  6. ELINGS W, Gaur A, Blok AJ, Timmer M, et al
    beta-Lactamase of Mycobacterium tuberculosis shows dynamics in the active site that increase upon inhibitor binding.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02025.
    PubMed     Text format     Abstract available


    BMJ

  7. HAQUE AKM, Bagtharia R, Rawal J
    Acute paraplegia in a healthy child.
    BMJ. 2019;367:l6257.
    PubMed     Text format    


    Clin Infect Dis

  8. BOGLIONE L, Lipani F, Lucchini AM, Salvador E, et al
    Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.
    Clin Infect Dis. 2019 Dec 17. pii: 5679635. doi: 10.1093/cid/ciz1199.
    PubMed     Text format    

  9. ALFFENAAR JC, Heysell SK, Mpagama SG
    Therapeutic Drug Monitoring: The Need for Practical Guidance.
    Clin Infect Dis. 2019;68:1065-1066.
    PubMed     Text format    

  10. NOLT D
    Granulomas and guidelines - the search for tuberculosis during TNF-alpha inhibition.
    Clin Infect Dis. 2019 Dec 4. pii: 5651255. doi: 10.1093/cid/ciz1139.
    PubMed     Text format    


    Emerg Infect Dis

  11. LUIS BAL, Diaz-Lomeli P, Gomez-Albarran LP, Martinez-Gamboa A, et al
    Mycobacterium obuense Bacteremia in a Patient with Pneumonia.
    Emerg Infect Dis. 2019;25:1015-1016.
    PubMed     Text format     Abstract available

  12. HIGGITT RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, et al
    Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.
    Emerg Infect Dis. 2019;25:1425-1427.
    PubMed     Text format     Abstract available

  13. BRODE SK, Chung H, Campitelli MA, Kwong JC, et al
    Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Emerg Infect Dis. 2019;25.
    PubMed     Text format     Abstract available


    Eur J Clin Microbiol Infect Dis

  14. WEIGL JAI
    Open flanks in the management of tuberculosis in Germany under the pressure of migration.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 17. pii: 10.1007/s10096-019-03791.
    PubMed     Text format     Abstract available


    Eur Respir J

  15. STEK C, Allwood B, Du Bruyn E, Buyze J, et al
    The effect of HIV-associated tuberculosis, tuberculosis-IRIS, and prednisone on lung function.
    Eur Respir J. 2019 Dec 20. pii: 13993003.01692-2019.
    PubMed     Text format     Abstract available

  16. DE VRIES G, Commandeur S, Erkens C, Haddad W, et al
    Towards selective tuberculosis screening of people in prison in a low-incidence country.
    Eur Respir J. 2019 Dec 20. pii: 13993003.02209-2019.
    PubMed     Text format    

  17. JONSSON J, Kuhlmann-Berenzon S, Berggren I, Bruchfeld J, et al
    Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden.
    Eur Respir J. 2019 Dec 20. pii: 13993003.01886-2019.
    PubMed     Text format     Abstract available


    Infect Immun

  18. RUIZ-TAGLE C, Naves R, Balcells ME
    Unraveling the role of microRNAs in Mycobacterium tuberculosis infection and disease: advances and pitfalls.
    Infect Immun. 2019 Dec 23. pii: IAI.00649-19. doi: 10.1128/IAI.00649.
    PubMed     Text format     Abstract available


    Int J Tuberc Lung Dis

  19. REIMANN M, Schaub D, Kalsdorf B, Runge C, et al
    Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Int J Tuberc Lung Dis. 2019;23:93-98.
    PubMed     Text format     Abstract available

  20. AGIZEW T, Boyd R, Auld AF, Payton L, et al
    Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:82-92.
    PubMed     Text format     Abstract available

  21. PEDRAZZOLI D, Borghi J, Viney K, Houben RMGJ, et al
    Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
    Int J Tuberc Lung Dis. 2019;23:5-11.
    PubMed     Text format     Abstract available

  22. AGGERBECK H, Ruhwald M, Hoff ST, Tingskov PN, et al
    Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
    Int J Tuberc Lung Dis. 2019;23:38-44.
    PubMed     Text format     Abstract available

  23. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    Sputum smear microscopy in the Xpert((R)) MTB/RIF era.
    Int J Tuberc Lung Dis. 2019;23:12-18.
    PubMed     Text format     Abstract available

  24. HARRIES AD, Timire C, Takarinda KC, Sandy C, et al
    Ensuring that Xpert((R)) MTB/RIF is used to its maximum potential.
    Int J Tuberc Lung Dis. 2019;23:1043-1044.
    PubMed     Text format    

  25. HARRIES AD, Chakaya JM
    Assessing and managing pulmonary impairment in those who have completed TB treatment in programmatic settings.
    Int J Tuberc Lung Dis. 2019;23:1044-1045.
    PubMed     Text format    

  26. JINDAL SK
    Searching for a mole in the hill.
    Int J Tuberc Lung Dis. 2019;23:1047.
    PubMed     Text format    

  27. TADYANEMHANDU C, Garvey C, Chin A, Metcalfe J, et al
    More should be done now for patients with TB-associated chronic lung disease.
    Int J Tuberc Lung Dis. 2019;23:1122-1123.
    PubMed     Text format    

  28. DOWDY DW
    Implementation of Xpert((R)) MTB/RIF: real challenges, real promise.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed     Text format    

  29. MISHRA B, Mohapatra PR
    Expand the RRDR hotspot to improve GeneXpert results.
    Int J Tuberc Lung Dis. 2019;23:1043.
    PubMed     Text format    


    J Bacteriol

  30. SOLER-ARNEDO P, Sala C, Zhang M, Cole ST, et al
    Polarly localized EccE1 is required for ESX-1 function and stabilization of ESX-1 membrane proteins in Mycobacterium tuberculosis.
    J Bacteriol. 2019 Dec 16. pii: JB.00662-19. doi: 10.1128/JB.00662.
    PubMed     Text format     Abstract available


    J Immunol

  31. HOOK JS, Cao M, Weng K, Kinnare N, et al
    Mycobacterium tuberculosis Lipoarabinomannan Activates Human Neutrophils via a TLR2/1 Mechanism Distinct from Pam3CSK4.
    J Immunol. 2019 Dec 23. pii: jimmunol.1900919. doi: 10.4049/jimmunol.1900919.
    PubMed     Text format     Abstract available

  32. WONG EA, Evans S, Kraus CR, Engelman KD, et al
    IL-10 Impairs Local Immune Response in Lung Granulomas and Lymph Nodes during Early Mycobacterium tuberculosis Infection.
    J Immunol. 2019 Dec 20. pii: jimmunol.1901211. doi: 10.4049/jimmunol.1901211.
    PubMed     Text format     Abstract available


    Lancet

  33. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    PubMed     Text format    


    Lancet Infect Dis

  34. ADEPOJU P
    Nigeria's widening tuberculosis gap.
    Lancet Infect Dis. 2020;20:29.
    PubMed     Text format    

  35. CAMPBELL JR, Trajman A, Cook VJ, Johnston JC, et al
    Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
    Lancet Infect Dis. 2019 Dec 19. pii: S1473-3099(19)30575.
    PubMed     Text format     Abstract available

  36. TIBERI S, Migliori GB
    What is the best regimen to treat latent tuberculosis infection?
    Lancet Infect Dis. 2019 Dec 19. pii: S1473-3099(19)30627.
    PubMed     Text format    

  37. BROGER T, Muyoyeta M, Kerkhoff AD, Denkinger CM, et al
    Tuberculosis test results using fresh versus biobanked urine samples with FujiLAM.
    Lancet Infect Dis. 2020;20:22-23.
    PubMed     Text format    


    PLoS One

  38. BLANKLEY S, Gashu T, Ahmad B, Belaye AK, et al
    Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe.
    PLoS One. 2019;14:e0214739.
    PubMed     Text format     Abstract available

  39. XU C, Li R, Shewade HD, Jeyashree K, et al
    Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    PLoS One. 2019;14:e0214943.
    PubMed     Text format     Abstract available

  40. DUNCAN K, Sinanovic E
    A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.
    PLoS One. 2019;14:e0214492.
    PubMed     Text format     Abstract available

  41. AGGARWAL AN, Agarwal R, Sehgal IS, Dhooria S, et al
    Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0213728.
    PubMed     Text format     Abstract available

  42. SHEWADE HD, Gupta V, Satyanarayana S, Pandey P, et al
    Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
    PLoS One. 2019;14:e0213345.
    PubMed     Text format     Abstract available

  43. YANG J, Lee S, Oh S, Han S, et al
    The risk of active tuberculosis among individuals living in tuberculosis-affected households in the Republic of Korea, 2015.
    PLoS One. 2019;14:e0225744.
    PubMed     Text format     Abstract available

  44. IZUDI J, Tamwesigire IK, Bajunirwe F
    Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis.
    PLoS One. 2019;14:e0226919.
    PubMed     Text format     Abstract available

  45. ARRIAGA MB, Torres NMC, Araujo NCN, Caldas SCC, et al
    Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    PLoS One. 2019;14:e0227101.
    PubMed     Text format     Abstract available

  46. CHAVES TORRES NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, et al
    Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.
    PLoS One. 2019;14:e0226507.
    PubMed     Text format     Abstract available

  47. ORINA F, Mwangi M, Meme H, Kitole B, et al
    Intrinsic and extrinsic factors associated with sputum characteristics of presumed tuberculosis patients.
    PLoS One. 2019;14:e0227107.
    PubMed     Text format     Abstract available

  48. ABONG J, Dalay V, Langley I, Tomeny E, et al
    Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.
    PLoS One. 2019;14:e0227093.
    PubMed     Text format     Abstract available

  49. FELLAG M, Loukil A, Saad J, Lepidi H, et al
    Translocation of Mycobacterium tuberculosis after experimental ingestion.
    PLoS One. 2019;14:e0227005.
    PubMed     Text format     Abstract available

  50. FATIMA R, Yaqoob A, Qadeer E, Hinderaker SG, et al
    Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children.
    PLoS One. 2019;14:e0227186.
    PubMed     Text format     Abstract available

  51. KANVATIRTH P, Jeeves RE, Bacon J, Besra GS, et al
    Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PLoS One. 2019;14:e0213713.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: